• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD AFFIRM¿ VPIII MICROBIAL IDENTIFICATION TEST; DNA PROBE, YEAST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD AFFIRM¿ VPIII MICROBIAL IDENTIFICATION TEST; DNA PROBE, YEAST Back to Search Results
Catalog Number 446252
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/28/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
D4.Medical device expiration date: unknown.H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.H4.Device manufacture date: unknown.
 
Event or Problem Description
It was reported that during use with the bd affirm¿ vpiii microbial identification test, a patient previously tested positive for gardnerella vaginalis, treated, and continued to test positive post treatment.The provider questioned the length of time the patient continued to test positive, and suspected the result was erroneous.No patient impact was reported.Report 2 of 5.
 
Event or Problem Description
It was reported that during use with the bd affirm¿ vpiii microbial identification test, a patient previously tested positive for gardnerella vaginalis, treated, and continued to test positive post treatment.The provider questioned the length of time the patient continued to test positive, and suspected the result was erroneous.No patient impact was reported.Report 2 of 5.
 
Additional Manufacturer Narrative
H.6.Investigation summary: bd did not receive returned samples or photos for investigation into customer claim of affirm gardnerella vaginalis (gv) false positives.Additionally, incident lot # was unable to be determined, so review of device history record and retention testing could not be conducted.If additional information is made available, this complaint will be reopened to assess the level of investigation needed.This complaint was unable to be confirmed for affirm gv false positives.Bd was unable to identify a root cause for indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD AFFIRM¿ VPIII MICROBIAL IDENTIFICATION TEST
Common Device Name
DNA PROBE, YEAST
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key19197590
Report Number1119779-2024-00319
Device Sequence Number7616269
Product Code MLA
UDI-Device Identifier00382904462529
UDI-Public(01)00382904462529
Combination Product (Y/N)N
Initial Reporter StateNE
Initial Reporter CountryUS
PMA/510(K) Number
K931374
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number446252
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/29/2024
Supplement Date Received by Manufacturer06/21/2024
Initial Report FDA Received Date04/26/2024
Supplement Report FDA Received Date07/19/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexFemale
-
-